Detection of breast cancer (BrCa) cells in patient peripheral blood stem cell (PBSC) and CD34 selected products using immunocytochemical (ICC) and tumor enrichment procedures.

被引：0
|
作者：
Umiel, T
Prilutskaya, M
Nguyen, NH
Moss, TJ
Burgess, J
Griffith, M
Mills, BJ
机构：
[1] Impath BIS Inc, Reseda, CA USA
[2] Nexell Therapeut Inc, Irvine, CA USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1843
引用
收藏
页码：446A / 446A
页数：1
相关论文
共 50 条
  • [11] Immunocytochemical detection of tumor cells in peripheral blood stem cell collection (PBSC) from patients with advanced ovarian carcinoma.
    DalCortivo, L
    Robert, I
    Extra, JM
    Lotz, JP
    Benbunan, M
    Marolleau, JP
    Zini, JM
    BLOOD, 1997, 90 (10) : 4324 - 4324
  • [12] Immunocytochemical (ICC) detection and clinical relevance of breast cancer cells detected in peripheral blood progenitor cell (PBPC) collections
    Kleinman, MB
    Wiley, EL
    Villa, M
    Guo, M
    Rademaker, A
    Tallman, MS
    Gordon, LI
    Newman, S
    Winter, JN
    BLOOD, 1996, 88 (10) : 2559 - 2559
  • [13] Improved detection of tumor cells by CD45 enrichment followed by immunocytochemical (ICC) detection in breast cancer patients undergoing autologous transplantation (ABMT).
    Noga, SJ
    Kennedy, MJ
    Valone, F
    Armstrong, D
    VanVlasselaer, P
    Moss, TJ
    BLOOD, 1996, 88 (10) : 3651 - 3651
  • [14] Sequential peripheral blood (PB) measurement of CD34 using the IMAGN® 2000 microvolume fluorimeter optimizes peripheral blood stem cell (PBSC) collection schedules.
    Noga, SJ
    Grayson, C
    Noffsinger, L
    Mulcahey, K
    Crabbin, SC
    Loper, K
    Vogelsang, GB
    Grever, M
    Borowitz, MJ
    Flinn, IW
    O'Donnell, PV
    BLOOD, 1998, 92 (10) : 304B - 304B
  • [15] Isolation of CD34(+) cells with the Amgen cell selection system provides T, NK and tumor cell depletion of peripheral blood stem cells from breast cancer patients.
    Symann, M
    Guillaume, T
    Salmon, M
    Briddell, R
    Zilm, K
    Canon, JL
    Andre, M
    Jurdan, M
    Johnsen, H
    Richel, D
    Myltenyi, S
    Ewen, C
    McNiece, I
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 254 - 254
  • [16] EVALUATION OF THE COLLECTION EFFICIENCY (CE) OF PERIPHERAL-BLOOD STEM-CELL (PBSC) BY CD34 POSITIVE CELLS AND CFU-GM
    ABE, T
    KAWANO, Y
    MAKIMOTO, A
    OKAMOTO, Y
    SAITO, S
    HIRAO, A
    SATO, J
    TAKAUE, Y
    KURODA, Y
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 822 - 822
  • [17] FACTORS AFFECTING CLINIMACS ENRICHMENT OF CD34+CELLS FROM PERIPHERAL BLOOD STEM CELL PRODUCTS: A SINGLE CENTER ANALYSIS OF 278 PROCEDURES
    Law, P.
    Triplett, B.
    Leung, W.
    Kang, G.
    Janssen, W.
    CYTOTHERAPY, 2016, 18 (06) : S84 - S84
  • [18] The prediction of breast cancer (BrCa) contamination in stem cell products by immunocytochemical analysis of pre-mobilized peripheral blood.
    Umiel, T
    George, S
    Joyce, RA
    Moss, TJ
    BLOOD, 2000, 96 (11) : 184A - 184A
  • [19] Detection of residual tumor cells in peripheral blood stem cells collections from breast and ovarian cancer patients using immunocytochemical technique
    DalCortivo, L
    Robert, I
    Extra, JM
    Lotz, JP
    Miclea, JM
    Benbunan, M
    Marolleau, JP
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 908 - 908
  • [20] Results of Using Automated Clinimacs Prodigy for CD34 Selection from Mobilized Peripheral Blood Stem Cell Products
    Bateman, Caroline M.
    Antonenas, Vicki
    Yehson, Kenneth
    Tong, Daochen
    Hansra, Gurdip
    Clancy, Leighton Edward
    Shaw, Peter J.
    Micklethwaite, Kenneth P.
    Gottlieb, David
    BLOOD, 2017, 130
12345